CA2221706A1 - Htnad29 recepteurs de proteines g - Google Patents
Htnad29 recepteurs de proteines g Download PDFInfo
- Publication number
- CA2221706A1 CA2221706A1 CA002221706A CA2221706A CA2221706A1 CA 2221706 A1 CA2221706 A1 CA 2221706A1 CA 002221706 A CA002221706 A CA 002221706A CA 2221706 A CA2221706 A CA 2221706A CA 2221706 A1 CA2221706 A1 CA 2221706A1
- Authority
- CA
- Canada
- Prior art keywords
- polypeptide
- receptor
- polynucleotide
- dna
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
Abstract
L'invention concerne des polypeptides récepteurs du facteur d'activation des plaquettes (PAF) de protéines G humaines, l'ADN (ARN) codant ces polypeptides ainsi qu'une méthode de production de tels polypeptides par des techniques de recombinaison. L'invention concerne également des procédés d'utilisation de ces polypeptides pour l'identification d'antagonistes et d'agonistes de ces polypeptides, ainsi que des procédés d'utilisation thérapeutique de ces agonistes et antagonistes dans le traitement des troubles liés à la sous-expression et à la surexpression des polypeptides récepteurs du facteur PAF. L'invention concerne également des méthodes de diagnostic permettant de déceler une mutation dans les séquences d'acides nucléiques des récepteurs du facteur PAF et permettant de déterminer un niveau de la forme soluble des récepteurs dans un échantillon tiré d'un hôte.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/007288 WO1996039442A1 (fr) | 1995-06-06 | 1995-06-06 | Htnad29 recepteurs de proteines g |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2221706A1 true CA2221706A1 (fr) | 1996-12-12 |
Family
ID=22249278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002221706A Abandoned CA2221706A1 (fr) | 1995-06-06 | 1995-06-06 | Htnad29 recepteurs de proteines g |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0832126A4 (fr) |
JP (1) | JPH11506341A (fr) |
KR (1) | KR19990022531A (fr) |
CN (1) | CN1147505C (fr) |
AU (1) | AU714642B2 (fr) |
CA (1) | CA2221706A1 (fr) |
WO (1) | WO1996039442A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221627B1 (en) | 1997-02-24 | 2001-04-24 | Smithkline Beecham Corporation | cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
US6555339B1 (en) * | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
US6733990B1 (en) | 1999-08-03 | 2004-05-11 | Millennium Pharmaceuticals, Inc. | Nucleic acid encoding 15571, a GPCR-like molecule of the secretin-like family |
EP2264068A1 (fr) * | 1998-10-13 | 2010-12-22 | Arena Pharmaceuticals, Inc. | Récepteurs non-endogènes de la protéine G humaine ayant une activité constitutive |
US6919176B2 (en) | 2001-05-07 | 2005-07-19 | Amgen Inc. | Polypeptides and nucleic acids associated with cancer |
AU2003206749A1 (en) * | 2002-02-01 | 2003-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with the gpr65 receptor |
MXPA05013721A (es) | 2003-06-20 | 2006-03-08 | Novartis Ag | Receptores acoplados con proteina-g de deteccion de protones, y secuencias de adn de los mismos. |
WO2008101354A1 (fr) * | 2007-02-22 | 2008-08-28 | Merck Frosst Canada Ltd | Gpr65 utilisé comme cible thérapeutique dans une inflammation allergique des voies respiratoires |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5262529A (en) * | 1990-01-24 | 1993-11-16 | President And Fellows Of Harvard College | Diagnosis of hereditary retinal degenerative diseases |
US5462856A (en) * | 1990-07-19 | 1995-10-31 | Bunsen Rush Laboratories, Inc. | Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
JPH06511386A (ja) * | 1991-10-01 | 1994-12-22 | アメリカ合衆国 | リガンドおよびリガンドのアンタゴニストを同定する方法 |
US5508384A (en) * | 1992-09-10 | 1996-04-16 | New York University | Polypeptide derived from a popamine receptor, and compositions and methods thereof |
US6066322A (en) * | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
-
1995
- 1995-06-06 CA CA002221706A patent/CA2221706A1/fr not_active Abandoned
- 1995-06-06 KR KR1019970709012A patent/KR19990022531A/ko not_active Application Discontinuation
- 1995-06-06 JP JP9500379A patent/JPH11506341A/ja active Pending
- 1995-06-06 EP EP95923763A patent/EP0832126A4/fr not_active Withdrawn
- 1995-06-06 AU AU28204/95A patent/AU714642B2/en not_active Ceased
- 1995-06-06 WO PCT/US1995/007288 patent/WO1996039442A1/fr not_active Application Discontinuation
- 1995-06-06 CN CNB951979256A patent/CN1147505C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR19990022531A (ko) | 1999-03-25 |
EP0832126A4 (fr) | 2000-01-12 |
JPH11506341A (ja) | 1999-06-08 |
AU2820495A (en) | 1996-12-24 |
EP0832126A1 (fr) | 1998-04-01 |
CN1147505C (zh) | 2004-04-28 |
CN1193980A (zh) | 1998-09-23 |
WO1996039442A1 (fr) | 1996-12-12 |
AU714642B2 (en) | 2000-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030023044A1 (en) | Human G-Protein chemokine receptor (CCR5) HDGNR10 | |
EP1369430A2 (fr) | Deux récepteurs couplés par des protéines G: GPCR2 induit par VEB (EBI-2) et GPCR de type GDE-1 | |
US20080241124A1 (en) | Human G-Protein Chemokine Receptor (CCR5) HDGNR10 | |
US20050214281A1 (en) | G-protein coupled receptor | |
US5861272A (en) | C5A receptor | |
US20050266527A1 (en) | Human G-protein receptor HIBEF51 | |
WO1996039435A1 (fr) | Recepteur hpraj70 de proteine g humaine | |
US20060148708A1 (en) | C5a receptor | |
AU714642B2 (en) | G-protein receptor HTNAD29 | |
US20020106740A1 (en) | Human G-protein receptor HPRAJ70 | |
US6338951B1 (en) | G-protein parathyroid hormone receptor HLTDG74 | |
EP0955808A1 (fr) | Recepteur couple de la proteine g humaine | |
EP1146055A2 (fr) | Chemokine recepteur HDGNR10 aux proteines G humaines (recepteur CCR5) | |
US20050123998A1 (en) | C5a receptor | |
EP1149582A2 (fr) | Récepteur humain de Chemokine aux protéines G:HDGNR10 (récepteur CCR5). Ses utilisations. | |
US20090036398A1 (en) | Human G-Protein Coupled Receptor (HETGQ23) | |
US20050059114A1 (en) | G-protein receptor HTNAD29 | |
US20080312178A1 (en) | Human G-Protein Receptor HGBER32 | |
CA2220978A1 (fr) | Recepteur couple de proteines g humaines (hetgq23) | |
AU760468B2 (en) | G-protein receptor HTNAD29 | |
US20050266522A1 (en) | Human amine receptor | |
US20060014243A1 (en) | Human G-protein chemokine receptor HSATU68 | |
US20030054487A1 (en) | Human G-protein coupled receptor | |
US20020106734A1 (en) | Adrenergic receptor | |
CA2221116A1 (fr) | Recepteur hltdg74 de l'hormone parathyroidienne (hpt) couple a la proteine g |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |